Takeda buys Baxalta Minnesota biologics plant
Takeda has snapped up Baxalta’s mammalian cell culture plant in Minnesota for the production of its monoclonal antibody Entyvio (vedolizumab).
Archives for January 8, 2016
Orthocell granted US patent for regenerative growth factor production
Orthocell has been granted a patent for its cell factory technology, which it says could produce ‘off-the-shelf’ growth factors for regenerating tissue and bone.
Personalised tissue will change drug development, says researcher
A recently developed stem cell programming technique could produce human tissue on-demand for testing new drug treatments.